Clinical Trial Details
| Trial ID: | L0331 |
| Source ID: | NCT03294941 |
| Associated Drug: | HepQuant SHUNT Liver Diagnostic Kit |
| Title: | The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology |
| Acronym: | -- |
| Status: | Terminated |
| Study Results: | Has Results |
| Results: | https://ClinicalTrials.gov/show/NCT03294941/results |
| Conditions: | NASH - Nonalcoholic Steatohepatitis |
| Interventions: | Combination Product: HepQuant SHUNT Liver Diagnostic Kit |
| Outcome Measures: | Baseline DSI|Change in DSI From Baseline to 48 Weeks|Severity of Liver Disease Index (DSI) Scores Stratified by Baseline NASH CRN Stage of Fibrosis |
| Sponsor/Collaborators: | HepQuant, LLC |
| Gender: | All |
| Age: | 18 Years to 70 Years ?? (Adult, Older Adult) |
| Phases: | Phase 2 |
| Enrollment: | 17 |
| Study Type: | Interventional |
| Study Designs: | Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic |
| Start Date: | December 8, 2017 |
| Completion Date: | September 11, 2019 |
| Results First Posted: | July 15, 2021 |
| Last Update Posted: | August 9, 2021 |
| Locations: | Schiff Center for Liver Diseases, Miami, Florida, United States|University of PA, Philadelphia, Pennsylvania, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|TX Digestive Disease Consultants, Dallas, Texas, United States|The Texas Liver Institute, San Antonio, Texas, United States|McGuire VA Med Cntr, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|University of Washingtion, Seattle, Washington, United States |
| URL: | https://ClinicalTrials.gov/show/NCT03294941 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|